Few overheating or already-surging signals — relatively calm. A good stage to observe pre-breakout conditions patiently.
Some risk factors present — volatility, short-term overheating, or thin liquidity. Size and scale in carefully if entering.
Already surged, RSI overheated, extended far from highs, or earnings imminent. Chasing now carries meaningful pullback risk.
BCAL's RSI(14) currently reads 58. RSI measures the ratio of recent gains to losses over the past 14 sessions to gauge overbought or oversold conditions. Readings above 70 are typically read as overbought and below 30 as oversold — this one falls in the 'normal' range. Treat this as one data point on BCAL, not a standalone signal. → Learn more
ADX currently reads 11. ADX quantifies how strongly a trend is persisting, independent of whether it's up or down (25+ is considered pronounced). Right now BCAL shows +DI sits above -DI, favoring the upside, putting it in the 'weak trend' range on ADX. As with any single metric, weigh this alongside BCAL's full indicator set. → Learn more
BCAL's Bollinger Band width is in the bottom 15% (narrow) of its past year, and the squeeze indicator is currently active. A squeeze flags that band width has narrowed to a low percentile versus its own trailing history. A squeeze is often followed by a volatility expansion in either direction. Cross-check this against BCAL's other indicators above before drawing a conclusion. → Learn more
BCAL's OBV is currently not showing a clear rise (none), and the up/down volume ratio is 1.2x. OBV is a running tally that infers buying or selling pressure purely from volume direction. Cross-check this against BCAL's other indicators above before drawing a conclusion. → Learn more
BCAL's recent volume is running at 1.3x its usual level. This ratio shows how many times normal volume the stock has been trading at lately — a reference point for whether order flow is concentrating around this stock. Treat this as one data point on BCAL, not a standalone signal. → Learn more
BCAL's change over the last 5 trading days is +2.1%, and over the last 1 trading day is -0.8%. These two numbers show recent short-term direction but say nothing about where the price goes next.
BCAL's current price is 1.1% below its 20-day high. Distance from the recent high is a reference point for how close price is to potential resistance. On this measure it currently falls in the 'near resistance' category. Treat this as one data point on BCAL, not a standalone signal. → Learn more
BCAL's ATR% currently reads 2.0%, a 'daily range' level. ATR% expresses how large the average daily move has been recently, as a percentage of price. This reading is specific to BCAL on this scan date and can change quickly. → Learn more
BCAL's 20-trading-day relative strength versus SPY (S&P 500 ETF) is +2.4%. BCAL gained more (or lost less) than SPY over this stretch. This reading is specific to BCAL on this scan date and can change quickly. → Learn more
Measured (n=3949), the hit-rate for Bollinger Band Squeeze (28.3%) was not statistically distinguishable from the base rate (29.3%). As with any single metric, weigh this alongside BCAL's full indicator set. → Bollinger Band Squeeze
Stocks holding ADX Trend Strengthening reached +15% 29.5% of the time, versus a 29.3% base rate — not a statistically significant difference (6731 cases). As with any single metric, weigh this alongside BCAL's full indicator set. → ADX Trend Strengthening
Stocks holding +DI Dominance reached +15% 27.0% of the time, versus a 29.3% base rate — not a statistically significant difference (8370 cases). This reading is specific to BCAL on this scan date and can change quickly. → +DI Dominance
Stocks holding Weekly Squeeze reached +15% 25.4% of the time, versus a 29.3% base rate — not a statistically significant difference (5281 cases). Treat this as one data point on BCAL, not a standalone signal. → Weekly Squeeze
No significant edge was measured for Weekly Tight Base 3+ Weeks: 2.0% versus a 29.3% base rate across 2081 cases. As with any single metric, weigh this alongside BCAL's full indicator set. → Weekly Tight Base 3+ Weeks
No significant edge was measured for Stage 2 Trend Template: 21.4% versus a 29.3% base rate across 1385 cases. As with any single metric, weigh this alongside BCAL's full indicator set. → Stage 2 Trend Template
Limitations of this page — Automatically calculated, not a stock recommendation. Score is a count of conditions met, not a prediction; base rates are historical measurements only (BCAL diagnostic as of 2026.09.09 13:18).